Log in

Accuray Stock Price, Forecast & Analysis (NASDAQ:ARAY)

$2.69
-0.06 (-2.18 %)
(As of 11/19/2019 02:19 AM ET)
Today's Range
$2.68
Now: $2.69
$2.79
50-Day Range
$2.49
MA: $2.72
$2.91
52-Week Range
$2.35
Now: $2.69
$5.40
Volume488,700 shs
Average Volume687,514 shs
Market Capitalization$239.48 million
P/E RatioN/A
Dividend YieldN/A
Beta1.96
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. The CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:ARAY
CUSIP00439710
Phone408-716-4600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$418.79 million
Book Value$0.46 per share

Profitability

Net Income$-16,430,000.00

Miscellaneous

Employees998
Market Cap$239.48 million
Next Earnings Date1/28/2020 (Estimated)
OptionableOptionable

Receive ARAY News and Ratings via Email

Sign-up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter.


Accuray (NASDAQ:ARAY) Frequently Asked Questions

What is Accuray's stock symbol?

Accuray trades on the NASDAQ under the ticker symbol "ARAY."

How were Accuray's earnings last quarter?

Accuray Incorporated (NASDAQ:ARAY) announced its quarterly earnings data on Tuesday, October, 29th. The medical equipment provider reported ($0.11) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.10) by $0.01. The medical equipment provider earned $89.58 million during the quarter, compared to the consensus estimate of $93.34 million. Accuray had a negative return on equity of 35.92% and a negative net margin of 4.02%. View Accuray's Earnings History.

When is Accuray's next earnings date?

Accuray is scheduled to release their next quarterly earnings announcement on Tuesday, January 28th 2020. View Earnings Estimates for Accuray.

What price target have analysts set for ARAY?

2 Wall Street analysts have issued 12 month target prices for Accuray's shares. Their forecasts range from $4.00 to $4.00. On average, they anticipate Accuray's share price to reach $4.00 in the next year. This suggests a possible upside of 48.7% from the stock's current price. View Analyst Price Targets for Accuray.

What is the consensus analysts' recommendation for Accuray?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Accuray in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Accuray.

Has Accuray been receiving favorable news coverage?

News coverage about ARAY stock has trended neutral recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Accuray earned a daily sentiment score of 0.3 on InfoTrie's scale. They also assigned media coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Accuray.

Are investors shorting Accuray?

Accuray saw a decline in short interest in the month of October. As of October 31st, there was short interest totalling 1,570,000 shares, a decline of 16.0% from the September 30th total of 1,870,000 shares. Based on an average daily trading volume, of 575,700 shares, the short-interest ratio is currently 2.7 days. Currently, 1.9% of the company's stock are short sold. View Accuray's Current Options Chain.

Who are some of Accuray's key competitors?

What other stocks do shareholders of Accuray own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Accuray investors own include Activision Blizzard (ATVI), NVIDIA (NVDA), Advanced Micro Devices (AMD), Intel (INTC), Tesla (TSLA), FireEye (FEYE), Netflix (NFLX), AVEO Pharmaceuticals (AVEO), Cypress Semiconductor (CY) and Starbucks (SBUX).

Who are Accuray's key executives?

Accuray's management team includes the folowing people:
  • Mr. Joshua H. Levine, Pres, CEO & Director (Age 61)
  • Mr. Andrew Kirkpatrick, Sr. VP & COO (Age 56)
  • Mr. Lionel Hadjadjeba, Sr. VP & Chief Customer Experience Officer (Age 60)
  • Mr. Shigeyuki Hamamatsu, Sr. VP & CFO (Age 46)
  • Mr. Patrick R. Spine, Sr. VP & Chief Admin. Officer

Who are Accuray's major shareholders?

Accuray's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Russell Investments Group Ltd. (3.22%), State of New Jersey Common Pension Fund D (0.72%), Mackay Shields LLC (0.46%), Adirondack Research & Management Inc. (0.34%), Systematic Financial Management LP (0.15%) and Parallel Advisors LLC (0.14%). Company insiders that own Accuray stock include Alaleh Nouri, Andrew J Kirkpatrick, Jesse Chew, Joseph E Whitters, Joshua Levine, Kevin Waters, Patrick Spine and Shigeyuki Hamamatsu. View Institutional Ownership Trends for Accuray.

Which institutional investors are selling Accuray stock?

ARAY stock was sold by a variety of institutional investors in the last quarter, including Adirondack Research & Management Inc., Mackay Shields LLC, SG Americas Securities LLC and Systematic Financial Management LP. Company insiders that have sold Accuray company stock in the last year include Andrew J Kirkpatrick, Jesse Chew, Joshua Levine, Patrick Spine and Shigeyuki Hamamatsu. View Insider Buying and Selling for Accuray.

Which institutional investors are buying Accuray stock?

ARAY stock was purchased by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, Russell Investments Group Ltd., Parallel Advisors LLC, Meeder Asset Management Inc. and California Public Employees Retirement System. Company insiders that have bought Accuray stock in the last two years include Joseph E Whitters and Joshua Levine. View Insider Buying and Selling for Accuray.

How do I buy shares of Accuray?

Shares of ARAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Accuray's stock price today?

One share of ARAY stock can currently be purchased for approximately $2.69.

How big of a company is Accuray?

Accuray has a market capitalization of $239.48 million and generates $418.79 million in revenue each year. The medical equipment provider earns $-16,430,000.00 in net income (profit) each year or ($0.15) on an earnings per share basis. Accuray employs 998 workers across the globe.View Additional Information About Accuray.

What is Accuray's official website?

The official website for Accuray is http://www.accuray.com/.

How can I contact Accuray?

Accuray's mailing address is 1310 CHESAPEAKE TERRACE, SUNNYVALE CA, 94089. The medical equipment provider can be reached via phone at 408-716-4600 or via email at investors.accuray.com.


MarketBeat Community Rating for Accuray (NASDAQ ARAY)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  303 (Vote Outperform)
Underperform Votes:  283 (Vote Underperform)
Total Votes:  586
MarketBeat's community ratings are surveys of what our community members think about Accuray and other stocks. Vote "Outperform" if you believe ARAY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARAY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel